There are 3161 resources available
Presentation of case/condition
Presenter: David O Reilly
Session: Mesothelioma and the role of multidisciplinary team
Resources:
Webcast
Challenges for EU regulators
Presenter: Juan Garcia Burgos
Session: Challenges in access to new oncology medicines
Resources:
Slides
Webcast
Introduction and scientific background
Presenter: Lizza Hendriks
Session: Next generation immunotherapies in thoracic malignancies
Resources:
Webcast
1814O - Breastfeeding in women with hormone receptor-positive breast cancer who conceived after temporary interruption of endocrine therapy: Results from the POSITIVE trial
Presenter: Fedro Peccatori
Session: Proffered paper session: Supportive and palliative care
Resources:
Abstract
Slides
Webcast
613MO - A phase I clinical trial evaluating exarafenib, a selective pan-RAF inhibitor in combination with binimetinib in NRAS-mutant (NRASMut) melanoma (Mel) & BRAF-altered solid tumors
Presenter: Philippe Cassier
Session: Mini oral session: Developmental therapeutics
Resources:
Abstract
Slides
Webcast
515MO - Encorafenib + cetuximab (EC) + FOLFIRI for BRAF V600E-mutant metastatic colorectal cancer (mCRC): Updated results from the BREAKWATER safety lead-in (SLI)
Presenter: Josep Tabernero
Session: Mini oral session: GI tumours, lower
Resources:
Abstract
Slides
Webcast
1O - The somatic mutation landscape of the normal and malignant pancreas
Presenter: Pantelis Nicola
Session: Proffered paper session 1: Basic science & Translational research
Resources:
Abstract
Webcast
711O - Avelumab + methotrexate to eradicate low-risk gestational trophoblastic tumors in first-line setting: TROPHAMET phase I/II trial
Presenter: Benoit You
Session: Proffered paper session: Gynaecological cancers
Resources:
Abstract
Slides
Webcast
LBA9 - Clinical insights from ultra-sensitive tumour-informed ctDNA tracking across the TRACERx cohort
Presenter: Charles Swanton
Session: Proffered paper session 1: Basic science & Translational research
Resources:
Abstract
Slides
Webcast
Surveillance/minimal intervention for good risk disease
Presenter: Derya Tilki
Session: Biochemical failure post-local therapy: An opportunity for tailored treatment?
Resources:
Slides
Webcast